Register to leave comments

  • News bot Oct. 1, 2025, 10:37 p.m.

    📋 KALVISTA PHARMACEUTICALS, INC. (KALV) - Executive Changes

    Filing Date: 2022-05-27

    Accepted: 2022-05-27 16:12:44

    Event Type: Executive Changes

    Event Details:

    KalVista Pharmaceuticals Inc (KALV) Announces Executive and Board Changes KalVista Pharmaceuticals Inc (KALV) announced changes to its leadership team and board of directors. Patrick Treanor was appointed. The position includes: Class II, all committee, Governance Committee. The change is effective as of May 25, 2022. Executive Changes Details:
    • Personnel Involved: Patrick Treanor, Daniel Soland
    • Actions: Appointed, Elected, Departed
    • Committee Assignments: all committee, Governance Committee
    • Board Classification: Class II

    👥 Executive & Board Changes:

    • Personnel Involved: Patrick Treanor, Daniel Soland
    • Actions: Appointed, Elected, Departed
    • Committee Assignments: all committee, Governance Committee
    • Effective Dates: May 25, 2022, May 26, 2022, May 27, 2022

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes

    Structured Data:

    • Company Name: KalVista Pharmaceuticals Inc
    • CIK: 0001348911
    • Ticker Symbol: KALV
    • Period End Date: 2022-05-25
    • Document Type: 8-K